{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:22:27Z","timestamp":1790403747747,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01063","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T04:41:45Z","timestamp":1590640905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres"],"prefix":"10.3389","volume":"11","author":[{"given":"Anil J.","family":"Trindade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tany","family":"Thaniyavarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Klasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen P.","family":"Tsveybel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souheil","family":"El-Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.healun.2017.05.030","article-title":"Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review","volume":"36","author":"Benden","year":"2017","journal-title":"J Heart Lung Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.healun.2017.03.017","article-title":"Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction","volume":"37","author":"Moniodis","year":"2018","journal-title":"J Heart Lung Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ctr.12899","article-title":"Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation","volume":"31","author":"Ensor","year":"2017","journal-title":"Clin Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/jamasurg.2014.2038","article-title":"Survival benefit of solid-organ transplant in the United States","volume":"150","author":"Rana","year":"2015","journal-title":"JAMA Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1513\/AnnalsATS.201606-507OC","article-title":"Survival benefit of lung transplantation in the modern era of lung allocation","volume":"14","author":"Vock","year":"2017","journal-title":"Ann Am Thorac Soc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/ajt.14492","article-title":"Patient-reported health outcomes in long-term lung transplantation survivors: A prospective cohort study","volume":"18","author":"Shahabeddin Parizi","year":"2018","journal-title":"Am J Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/ajt.14081","article-title":"Effect of lung transplantation on health-related quality of life in the era of the lung allocation score: A U.S. Prospective Cohort Study","volume":"17","author":"Singer","year":"2017","journal-title":"Am J Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chest.2016.04.014","article-title":"Advances in understanding bronchiolitis obliterans after lung transplantation","volume":"150","author":"Verleden","year":"2016","journal-title":"Chest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/thoraxjnl-2014-205998","article-title":"A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation","volume":"70","author":"Corris","year":"2015","journal-title":"Thorax."},{"key":"B13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1432-2277.2011.01248.x","article-title":"Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study","volume":"24","author":"Verleden","year":"2011","journal-title":"Transpl Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0193564","DOI":"10.1371\/journal.pone.0193564","article-title":"Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial","volume":"13","author":"Ruttens","year":"2018","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.healun.2018.11.014","article-title":"Montelukast in chronic lung allograft dysfunction after lung transplantation","volume":"38","author":"Vos","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40262-017-0573-x","article-title":"Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation","volume":"57","author":"van der Zwan","year":"2018","journal-title":"Clin Pharmacokinet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1111\/j.1600-6143.2007.02000.x","article-title":"Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation","volume":"7","author":"Reams","year":"2007","journal-title":"Am J Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1378\/chest.14-0631","article-title":"Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease","volume":"147","author":"George","year":"2015","journal-title":"Chest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat Rev Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1073\/pnas.0807057106","article-title":"Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia","volume":"106","author":"Calado","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fimmu.2018.00076","article-title":"The Immunome in Two Inherited Forms of Pulmonary Fibrosis","volume":"9","author":"El-Chemaly","year":"2018","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1172\/JCI120216","article-title":"Short telomere syndromes cause a primary T cell immunodeficiency","volume":"128","author":"Wagner","year":"2018","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1513\/AnnalsATS.201808-508CME","article-title":"Telomeres in interstitial lung disease: the short and the long of It","volume":"16","author":"Courtwright","year":"2019","journal-title":"Ann Am Thorac Soc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.healun.2017.02.020","article-title":"Broadening the investigation-short telomeres and lung transplantation outcomes in pulmonary fibrosis","volume":"36","author":"Courtwright","year":"2017","journal-title":"J Heart Lung Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/thoraxjnl-2016-209897","article-title":"Short lung transplant donor telomere length is associated with decreased CLAD-free survival","volume":"72","author":"Faust","year":"2017","journal-title":"Thorax."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1600-6143.2011.03849.x","article-title":"Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation","volume":"12","author":"Davis","year":"2012","journal-title":"Am J Transplant."},{"key":"B28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1189\/jlb.70.6.861","article-title":"Interplay between telomere length and telomerase in human leukocyte differentiation and aging","volume":"70","author":"Weng","year":"2001","journal-title":"J Leukoc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","article-title":"Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival","volume":"36","author":"Newton","year":"2017","journal-title":"J Heart Lung Transplant."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T07:45:47Z","timestamp":1666683947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2020.01063"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01063","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"article-number":"1063"}}